StemRIM Future Growth
Future criteria checks 0/6
StemRIM's revenue and earnings are forecast to decline at 48.3% and 38.4% per annum respectively. EPS is expected to decline by 53.9% per annum. Return on equity is forecast to be -28.5% in 3 years.
Key information
-38.4%
Earnings growth rate
-53.9%
EPS growth rate
Biotechs earnings growth | 22.2% |
Revenue growth rate | -48.3% |
Future return on equity | -28.5% |
Analyst coverage | Low |
Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
7/31/2026 | 540 | -1,765 | -840 | -801 | 1 |
7/31/2025 | 540 | -1,679 | -748 | -709 | 1 |
7/31/2024 | 1,000 | -1,294 | -372 | -333 | 1 |
1/31/2024 | 2,350 | 179 | 608 | 610 | N/A |
10/31/2023 | 2,350 | 214 | N/A | N/A | N/A |
7/31/2023 | 2,350 | 168 | 1,135 | 1,135 | N/A |
4/30/2023 | 2,350 | 332 | N/A | N/A | N/A |
1/31/2023 | N/A | -1,957 | -1,428 | -1,428 | N/A |
10/31/2022 | N/A | -1,971 | N/A | N/A | N/A |
7/31/2022 | 22 | -1,948 | -1,404 | -1,404 | N/A |
4/30/2022 | 1,212 | -788 | N/A | N/A | N/A |
1/31/2022 | 1,212 | -813 | -356 | -295 | N/A |
10/31/2021 | 1,212 | -811 | N/A | N/A | N/A |
7/31/2021 | 1,400 | -582 | -608 | -519 | N/A |
4/30/2021 | 1,910 | -501 | N/A | N/A | N/A |
1/31/2021 | 2,310 | 89 | 14 | 191 | N/A |
10/31/2020 | 2,310 | 358 | N/A | N/A | N/A |
7/31/2020 | 2,100 | 347 | 423 | 575 | N/A |
4/30/2020 | 400 | -662 | N/A | N/A | N/A |
7/31/2019 | 100 | -721 | -783 | -777 | N/A |
7/31/2018 | 200 | -323 | N/A | N/A | N/A |
7/31/2017 | 300 | -123 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4599's earnings are forecast to decline over the next 3 years (-38.4% per year).
Earnings vs Market: 4599's earnings are forecast to decline over the next 3 years (-38.4% per year).
High Growth Earnings: 4599's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4599's revenue is expected to decline over the next 3 years (-48.3% per year).
High Growth Revenue: 4599's revenue is forecast to decline over the next 3 years (-48.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4599 is forecast to be unprofitable in 3 years.